183 related articles for article (PubMed ID: 62615)
1. Investigational drugs under study by the United States National Cancer Institute.
Carter SK; Slavik M
Cancer Treat Rev; 1976 Mar; 3(1):43-60. PubMed ID: 62615
[No Abstract] [Full Text] [Related]
2. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
Carter SK; Slavik M
Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134
[No Abstract] [Full Text] [Related]
3. [New substances in oncologic therapy].
Cavalli F; Brunner KW
Dtsch Med Wochenschr; 1978 Jul; 103(27):1087-92. PubMed ID: 78789
[No Abstract] [Full Text] [Related]
4. Anticancer chemotherapy.
Davey P; Tudhope GR
Br Med J (Clin Res Ed); 1983 Jul; 287(6385):110-3. PubMed ID: 6407699
[No Abstract] [Full Text] [Related]
5. Drugs used in the treatment of cancer.
Connors TA
FEBS Lett; 1975 Oct; 57(3):223-33. PubMed ID: 1102331
[No Abstract] [Full Text] [Related]
6. Overview of early and investigational chemotherapeutic agents in solid tumors.
Rozencweig M; Slavik M; Muggia FM; Carter SK
Med Pediatr Oncol; 1976; 2(4):417-32. PubMed ID: 137356
[TBL] [Abstract][Full Text] [Related]
7. [New antineoplastic agents, their value and use].
Pawlicki M; Zuchowska-Vogelgesang B
Przegl Lek; 1982 Sep; 39(8):561-5. PubMed ID: 6182581
[No Abstract] [Full Text] [Related]
8. New agents in non-small cell lung cancer.
Joss RA; Cavalli F; Goldhirsch A; Mermillod B; Brunner KW
Cancer Treat Rev; 1984 Sep; 11(3):205-36. PubMed ID: 6395953
[No Abstract] [Full Text] [Related]
9. [Models and methods used for the selection of antitumor preparations in the USSR and abroad].
Sof'ina ZP
Vopr Onkol; 1976; 22(4):82-96. PubMed ID: 1274284
[No Abstract] [Full Text] [Related]
10. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
Venditti JM; Wesley RA; Plowman J
Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
[No Abstract] [Full Text] [Related]
11. [New ways of the chemotherapy of cancer].
Schmidt CG
Krebsarzt; 1969; 24(3):129-49. PubMed ID: 5809854
[No Abstract] [Full Text] [Related]
12. [New substances in oncologic therapy].
Cavalli F
Schweiz Med Wochenschr; 1978 Aug; 108(32):1222-7. PubMed ID: 150028
[TBL] [Abstract][Full Text] [Related]
13. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Carter SK; Schabel FM; Broder LE; Johnston TP
Adv Cancer Res; 1972; 16():273-332. PubMed ID: 4563045
[No Abstract] [Full Text] [Related]
14. An outline of cancer chemotherapy.
Connors TA
Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
[No Abstract] [Full Text] [Related]
15. ICRF-187 in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
[TBL] [Abstract][Full Text] [Related]
16. Some thoughts on experimental models and their clinical correlations.
Carter SK
Eur J Cancer (1965); 1973; 9(11-12):833-41. PubMed ID: 4804310
[No Abstract] [Full Text] [Related]
17. [Foundations of the therapy of inoperable malignomas and hemoblastoses].
Stacher A
Wien Med Wochenschr; 1976 Jan; 126(5):51-4. PubMed ID: 948909
[No Abstract] [Full Text] [Related]
18. Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Holm B; Sehested M; Jensen PB
Clin Cancer Res; 1998 Jun; 4(6):1367-73. PubMed ID: 9626452
[TBL] [Abstract][Full Text] [Related]
19. [Platinum complexes as potential antineoplastic drugs].
Kuduk-Jaworska J
Postepy Hig Med Dosw; 1984; 38(3):281-322. PubMed ID: 6398870
[No Abstract] [Full Text] [Related]
20. [Introduction of new screening system in National Cancer Institute].
Tsukagoshi S
Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
